We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

52 hedge funds and large institutions have $138M invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2015 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 5

180% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 10

53% more funds holding

Funds holding: 34 → 52 (+18)

14% more capital invested

Capital invested by funds: $120M → $138M (+$17.4M)

Holders
52
Holders Change
+18
Holders Change %
+52.94%
% of All Funds
1.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
16
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.9M
2
BI
BVF Inc
California
+$11.1M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$5.4M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.92M
5
GTC
Ghost Tree Capital
New York
+$4.05M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$3.44M
2
EI
EAM Investors
California
-$1.31M
3
ARTA
A.R.T. Advisors
New York
-$684K
4
Citadel Advisors
Citadel Advisors
Florida
-$451K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$344K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$33.7M +$15.9M +1,177,300 +69%
NMC
2
NEA Management Company
Maryland
$30.6M – – –
BI
3
BVF Inc
California
$18.5M +$11.1M +823,500 +109%
AIC
4
AWM Investment Company
New York
$10.2M +$634K +47,000 +6%
WT
5
Wellcome Trust
United Kingdom
$4.95M -$223K -16,523 -4%
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$4.68M +$5.4M +400,000 New
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$4.27M +$4.92M +365,000 New
GTC
8
Ghost Tree Capital
New York
$3.51M +$4.05M +300,000 New
BIT
9
BlackRock Institutional Trust
California
$3.13M +$3.6M +267,147 New
JP Morgan Chase
10
JP Morgan Chase
New York
$3.06M +$2.17M +160,560 +160%
Vanguard Group
11
Vanguard Group
Pennsylvania
$2.96M +$1.69M +125,095 +98%
BBA
12
Baker Bros. Advisors
New York
$2.2M +$2.53M +187,597 New
BFA
13
BlackRock Fund Advisors
California
$2.12M +$2.44M +180,809 New
Millennium Management
14
Millennium Management
New York
$2.07M +$2.19M +162,676 +1,177%
Goldman Sachs
15
Goldman Sachs
New York
$1.9M +$1.76M +130,700 +414%
PI
16
Putnam Investments
Massachusetts
$1.64M +$1.89M +140,000 New
BA
17
BlackRock Advisors
Delaware
$1.15M +$1.32M +98,077 New
Northern Trust
18
Northern Trust
Illinois
$870K +$188K +13,915 +23%
GCP
19
GSA Capital Partners
United Kingdom
$807K +$929K +68,877 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$789K +$324K +24,032 +55%
State Street
21
State Street
Massachusetts
$703K +$409K +30,340 +102%
Alyeska Investment Group
22
Alyeska Investment Group
Illinois
$427K +$492K +36,441 New
HCM
23
Highbridge Capital Management
New York
$414K +$476K +35,315 New
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
$407K +$468K +34,733 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$381K +$181K +13,450 +70%
1
2 3

VTAE Hedge Fund Activity: Q1 2015 in Review

52 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q1 2015, worth a combined $138M — up 14% from $120M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new VTAE positions and 10 closed out — a net gain of 18 holders — while 16 added to existing stakes and 5 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $15.9M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $3.44M sold.

  • 52 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q1 2015, up from 34 in Q4 2014.
  • Funds reported $138M of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q1 2015, up 14% quarter-over-quarter.
  • 28 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q1 2015 and 10 closed out, a net change of +18 holders.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK buyer in Q1 2015 was Fidelity Investments, an estimated $15.9M added.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q1 2015 was EcoR1 Capital, an estimated $3.44M sold.

Based on aggregated 13F filings for Q1 2015.